Elio Labs
AI-Powered Optical Imaging Platform
Company Overview
Snapshot
Founded in May 2022 by Nadav Grossinger, Elio Labs operates with 11–50 employees. The company has secured funding across two rounds from four investors, with Innovation Endeavors leading a round in July 2026.
Business overview
Elio Labs develops a technology platform that integrates advanced optical imaging with artificial intelligence to analyze biological samples. This solution provides high-resolution, real-time insights into cells and tissues, supporting applications in drug discovery, disease research, and experimental biology. The company's approach enhances the speed, accuracy, and scalability of biological data interpretation through computational analysis combined with microscopy-based sensing, primarily serving the Health Tech & Life Sciences sector.
Strategic signal
This investment signals strong investor confidence in Elio Labs' AI-powered optical imaging platform and its potential to revolutionize biological sample analysis, particularly for applications in drug discovery and disease research.
Company Intelligence Q&A
- When was Elio Labs founded?
- Elio Labs was founded in May 2022.
- Who is the co-founder and CEO of Elio Labs?
- Nadav Grossinger is the co-founder and CEO of Elio Labs.
- What is Elio Labs' primary focus?
- Elio Labs focuses on developing an AI-powered optical imaging platform that analyzes biological samples at high resolution and in real time, enabling dynamic biological insights for drug discovery and disease research.